Home Articles List Article Information
Ain Shams Journal of Forensic Medicine and Clinical Toxicology
Journal Archive
Volume Volume 36 (2021)
Volume Volume 35 (2020)
Volume Volume 34 (2020)
Volume Volume 33 (2019)
Volume Volume 32 (2019)
Volume Volume 31 (2018)
Volume Volume 30 (2018)
Volume Volume 29 (2017)
Volume Volume 28 (2017)
Volume Volume 27 (2016)
Volume Volume 26 (2016)
Volume Volume 25 (2015)
Volume Volume 24 (2015)
Volume Volume 23 (2014)
Volume Volume 22 (2014)
Volume Volume 21 (2013)
Volume Volume 20 (2013)
Volume Volume 19 (2012)
Abbas, M., El-sherbeney, S., Ahmed, R. (2016). The Possible Ameliorative effect of Zafirlukast on Renal Toxicity Induced by Methotrexate in Experimental Animals. Ain Shams Journal of Forensic Medicine and Clinical Toxicology, 27(2), 92-104. doi: 10.21608/ajfm.2016.18323
Mohammed Abbas; Shereen El-sherbeney; Rasha Ahmed. "The Possible Ameliorative effect of Zafirlukast on Renal Toxicity Induced by Methotrexate in Experimental Animals". Ain Shams Journal of Forensic Medicine and Clinical Toxicology, 27, 2, 2016, 92-104. doi: 10.21608/ajfm.2016.18323
Abbas, M., El-sherbeney, S., Ahmed, R. (2016). 'The Possible Ameliorative effect of Zafirlukast on Renal Toxicity Induced by Methotrexate in Experimental Animals', Ain Shams Journal of Forensic Medicine and Clinical Toxicology, 27(2), pp. 92-104. doi: 10.21608/ajfm.2016.18323
Abbas, M., El-sherbeney, S., Ahmed, R. The Possible Ameliorative effect of Zafirlukast on Renal Toxicity Induced by Methotrexate in Experimental Animals. Ain Shams Journal of Forensic Medicine and Clinical Toxicology, 2016; 27(2): 92-104. doi: 10.21608/ajfm.2016.18323

The Possible Ameliorative effect of Zafirlukast on Renal Toxicity Induced by Methotrexate in Experimental Animals

Article 9, Volume 27, Issue 2, Summer and Autumn 2016, Page 92-104  XML PDF (1.17 MB)
Document Type: Original Article
DOI: 10.21608/ajfm.2016.18323
Authors
Mohammed Abbas1; Shereen El-sherbeney1; Rasha Ahmed2
1Department of Forensic Medicine and Clinical Toxicology, Faculty of medicine, Minia University, Egypt.
2Department of Biochemistry, Faculty of medicine, Minia University, Egypt.
Abstract
Methotrexate is a chemotherapeutic agent. Nephrotoxicity is an important side effect of treatment with methotrexate. Zafirlukast is a cystenyl leukotriene antagonist that acts as an anti-inflammatory and antioxidant agent. The aim of this study was to analyze the nephrotoxicity induced by methotrexate in rats and to evaluate the possible ameliorative effect of zafirlukast. Ethanol (1ml/kg, orally once daily) and  zafirlukast (40mg/kg, orally once daily) were given for 10 days. Methotrexate (20mg/kg I.P, single injection) and, zafirlukast (40mg/kg, orally once daily) was given 5 days before methtrexate and then 5 days after the chemotherapeutic agent. Rats will be sacrificed after the 10th day from methotrexate intake. Rats given methotrexate alone had significantly higher MDA (malondialdehyde), lower reduced glutathione, catalase, superoxide dismutase in kidney tissue and higher blood urea nitrogen and serum creatinine levels than the control groups. Co-treatment of zafirlukast with methotrexate had an ameliorative effect on the previous parameters. Light & electronic microscopic pictures revealed that methotrexate caused marked degenerative changes in the kidney of rats. Restoration of the normal architecture of kidney tissues were observed in rats received methotrexate with zafirlukast. Thus, methotrexate can induce oxidative damage in rat kidney & zafirlukast has an ameliorative effect against this damage
Keywords
Methotrexate; Nephrotoxicity; zafirlukast; oxidative damage
Statistics
Article View: 70
PDF Download: 104